A significant milestone has been reached for ceramic hip resurfacing in Canada.
In August 2026, Health Canada confirmed that the ceramic hip resurfacing device used for this procedure is a licensed medical device in Canada. As a result, individual authorization through Health Canada’s Special Access Programme is no longer required.
For patients considering hip resurfacing, this represents an important development in the availability of a metal-free, bone-preserving alternative to total hip replacement.
The regulatory milestone also comes at a time when published five-year clinical and registry data are providing encouraging information about ceramic hip resurfacing outcomes.
What Does Health Canada Licensing Mean?
Medical devices in Canada are regulated by Health Canada under the Medical Devices Regulations.
On August 4, 2026, Health Canada’s Medical Devices Directorate confirmed in correspondence to Dr. John Antoniou that Special Access authorization was no longer required for the ceramic resurfacing head and cup because the device is licensed in Canada under Medical Device Licence #115850.
In practical terms, the device is now licensed for importation and sale in Canada and no longer requires individual authorization through the Special Access Programme.
This is an important distinction for patients. Ceramic hip resurfacing can now be discussed as a treatment using a medical device licensed in Canada rather than one requiring patient-specific Special Access authorization.
From Limited Access to a Licensed Medical Device
Until recently, access to ceramic hip resurfacing in Canada was considerably more limited.
For patients and surgeons, the new licensing status changes the pathway through which the technology can be made available in Canada.
Health Canada’s confirmation that Special Access authorization is no longer required removes an important regulatory access step that previously applied to the device.
However, licensing does not mean that ceramic hip resurfacing is appropriate for every patient.
Hip resurfacing remains a specialized surgical procedure, and careful patient selection, appropriate anatomy, bone quality and surgical expertise remain essential considerations.
Why Was Ceramic Hip Resurfacing Developed?
Hip resurfacing is a bone-preserving alternative to conventional total hip replacement.
Instead of removing the entire femoral head and neck, as occurs during a traditional total hip replacement, resurfacing preserves more of the patient’s natural femoral bone while replacing the damaged joint surfaces.
Potential advantages of hip resurfacing for appropriately selected patients include:
- Preservation of more natural bone
- A larger femoral head
- Greater joint stability
- A lower risk of dislocation
- More natural hip biomechanics
- The potential to maintain a high level of physical activity
Historically, hip resurfacing has predominantly used cobalt-chrome metal-on-metal bearing surfaces.
Metal hip resurfacing has a long clinical history and can provide excellent outcomes in appropriately selected patients. However, concerns regarding metal ions and adverse reactions to metal debris have limited its suitability for some individuals.
Ceramic hip resurfacing maintains the bone-preserving principles of traditional resurfacing while replacing the metal-on-metal bearing with advanced ceramic bearing surfaces.
Because ceramic does not release metal ions, it offers an alternative for patients seeking to avoid metal-on-metal articulation.
Health Canada Licensing Comes Alongside Growing 5-Year Evidence
The change in regulatory status comes alongside another important development: the availability of published five-year follow-up data.
Recent national joint registry data has reported survivorship of up to 99.5% at five years for ceramic hip resurfacing.
In addition, a published international multicenter study involving 604 ceramic hip resurfacing procedures reported 98% survivorship at five years.
The study included 336 men and 268 women with an average age of approximately 50 years and reported significant improvements in patient function and activity levels following surgery.
These results provide important mid-term information about the performance of ceramic hip resurfacing.
Longer-term follow-up remains important and will continue to provide additional information about outcomes over time.
What Do the Results Show for Women?
Historically, surgeons have often been more selective when considering traditional metal hip resurfacing for women.
Some metal-on-metal resurfacing systems have reported less predictable outcomes in women and in patients requiring smaller implant sizes.
Recent ceramic hip resurfacing data has reported encouraging results in this population.
In the published multicenter study, five-year survivorship was:
- 98.5% in women
- 97.6% in men
There was no statistically significant difference in revision risk between male and female patients.
These findings are encouraging and suggest that ceramic hip resurfacing may have a role in a broader patient population than has traditionally been considered for metal-on-metal resurfacing.
Patient selection nevertheless remains essential, and gender alone does not determine whether someone is an appropriate candidate.
What About Patients With Smaller Hip Anatomy?
Implant size has also historically been an important consideration in hip resurfacing.
The published five-year study reported:
- 98.5% survivorship with smaller implant sizes
- 97.5% survivorship with larger implant sizes
No significant difference in revision risk based on implant size was reported.
These findings provide additional information for surgeons evaluating patients with different anatomical characteristics.
What Does Health Canada Licensing Mean for Canadian Patients?
For Canadian patients, the most immediate change is the regulatory pathway through which the ceramic resurfacing device is available.
Individual Special Access authorization is no longer required because the device is licensed in Canada.
Patients interested in ceramic hip resurfacing can therefore focus on the more important clinical question:
Is ceramic hip resurfacing the right procedure for me?
That decision requires a comprehensive orthopedic evaluation that considers:
- Age
- Bone density and bone quality
- Hip anatomy
- Severity of arthritis
- Activity level
- Medical history
- Expectations following surgery
- Long-term functional goals
For some patients, ceramic hip resurfacing may be an appropriate option. For others, traditional metal hip resurfacing or total hip replacement may remain the better choice. Patients who are comparing these approaches can also read our guide to hip resurfacing vs. total hip replacement.
What Does This Mean for U.S. Patients?
The Canadian licensing milestone may also be important for American patients researching ceramic hip resurfacing.
Access to ceramic hip resurfacing remains limited in the United States. For appropriately selected U.S. patients willing to travel, Montréal provides access to ceramic hip resurfacing within the Canadian medical-device regulatory framework.
Dr. John Antoniou regularly evaluates patients from the United States who are exploring alternatives to conventional total hip replacement.
The process can begin remotely with a consultation and review of appropriate medical imaging before determining whether ceramic hip resurfacing may be suitable.
For American patients, the decision to travel for surgery should consider not only access to the technology but also surgical experience, candidacy, costs, travel requirements, postoperative care and follow-up.
Ceramic vs. Metal Hip Resurfacing
The licensing of ceramic hip resurfacing does not mean that traditional metal hip resurfacing no longer has a role.
Metal hip resurfacing has more than two decades of clinical experience and continues to provide excellent results in carefully selected patients, particularly younger active men with:
- Strong bone quality
- Larger joint sizes
- Favorable femoral head anatomy
- High activity levels
Ceramic hip resurfacing provides another option.
Its metal-free bearing surface avoids metal ion exposure, while recent five-year data has reported encouraging results in both men and women and across different implant sizes.
The appropriate choice depends on the individual patient rather than simply choosing one technology over another.
Who May Be a Candidate for Ceramic Hip Resurfacing?
Ceramic hip resurfacing may be considered for active patients with significant hip arthritis who wish to preserve as much natural bone as possible.
Potential candidates may include individuals who:
- Lead an active lifestyle
- Have appropriate bone quality
- Have anatomy suitable for hip resurfacing
- Prefer a metal-free bearing surface
- Want to preserve more of their natural femoral bone
- May not be ideal candidates for traditional metal-on-metal resurfacing
Not every patient with hip arthritis is a candidate.
Detailed imaging and an orthopedic evaluation are required before determining whether ceramic resurfacing, metal resurfacing or total hip replacement is the most appropriate option.
What Happens Next?
For patients considering ceramic hip resurfacing, the first step is a consultation.
Dr. John Antoniou will review your medical history, symptoms, activity level, imaging and long-term goals to determine which treatment options are appropriate.
For patients outside Montréal, including those in the United States, the initial evaluation can begin remotely before travel is considered.
A New Chapter for Ceramic Hip Resurfacing in Canada
The licensing of ceramic hip resurfacing in Canada represents an important development in the evolution of bone-preserving hip surgery.
Health Canada’s confirmation that the ceramic resurfacing device is licensed means that individual Special Access authorization is no longer required.
At the same time, published five-year registry and multicenter data are providing increasingly valuable information about survivorship, function, activity levels and outcomes across different patient populations.
Long-term follow-up remains important, and ceramic hip resurfacing will not be appropriate for every patient. However, for carefully selected individuals seeking a bone-preserving, metal-free alternative to conventional total hip replacement, this development represents an important expansion of the treatment options available in Canada.
Schedule a Consultation
If you are considering ceramic hip resurfacing and would like to determine whether you may be a candidate, schedule a consultation with Dr. John Antoniou.
Canadian and U.S. patients can begin with an individualized assessment to review their imaging, anatomy, activity goals and available treatment options.
Sources
- Health Canada — Letter of Exemption from Special Access Requirements, August 4, 2026. The letter confirms that the ceramic resurfacing head and cup are licensed medical devices (Licence #115850) and that Special Access authorization is therefore not required.
- Health Canada — Medical Devices Active Licence Listing (MDALL). Health Canada explains that its database contains licensed Class II, III and IV devices offered for sale in Canada and that only products in the active listing may be offered for general marketing purposes.
Health Canada MDALL - Health Canada — Medical Device Licensing. Health Canada states that Class II, III and IV devices require a Medical Device Licence before they can be sold on the Canadian market.
Health Canada: About Medical Devices - Published multicenter ceramic hip resurfacing study — 604 procedures with five-year follow-up. Used for the 98% five-year survivorship, male/female results, implant-size findings, and functional/activity outcomes discussed above. [I would link the actual journal/PubMed citation on the live article rather than the product name in the body.]
- Australian national joint registry data. Used for the reported survivorship of up to 99.5% at five years. [I would link directly to the applicable registry report/table on the live article.]